In the afternoon of January 8, 2018, Professor Ming-Wei Wang (Director, the National Center for Drug Screening/Chinese National Compound Library and Dean, School of Pharmacy, Fudan University) was invited to attend the UBS (United Bank of Switzerland) Greater China Conference 2018 (From factory to laboratory: China’s transformation), held at Pudong Shangri-La Hotel, Shanghai. In Track 2 entitled “Future Accelerated ‒ Booming Innovation in Asia and China”, he interacted enthusiastically with the moderator, Mr. Niall MacLeod (Head of APAC Equity Strategy Research, UBS), Mr. Charles Zhang (Managing Partner, DT Capital Partners), Mr. Yankun Hou (Head of China Research, Chief China Strategist, UBS) and the audience, discussing various topics about the current status and future prospect of innovation and entrepreneurship in China.